Overview

Felix provides an online platform that allows patients to receive medical treatment without needing to visit a doctor's office or pharmacy. The process is straightforward: patients first answer health-related questions on the Felix platform, then a healthcare practitioner from Felix's network develops a personalized treatment plan, and finally, the prescribed medication is delivered directly to the patient's home in discreet packaging at no extra cost. This service is designed for those who prioritize convenience, privacy, and timely access to healthcare. Unlike many competitors, Felix emphasizes compassion and non-judgment in its approach, aiming to eliminate stigma and support patients throughout their treatment journey. With over 500,000 Canadians using its services, Felix is focused on providing a user-friendly experience and maintaining a high level of professionalism in healthcare.

Simplify's Take

What believers are saying

• Felix raised CDN$18M in Series B funding to expand service offerings.
• Partnership with Consonant Skincare diversifies product offerings and revenue streams.
• Increased demand for virtual mental health services boosts Felix's market potential.

What critics are saying

• Competition from established telemedicine platforms like Maple and Babylon Health is increasing.
• Potential regulatory challenges could impact Felix's operational processes in Canada.
• Data privacy concerns may affect customer trust in telemedicine platforms.

What makes felix unique

• Felix offers a seamless three-step healthcare process for Canadian patients.
• The company emphasizes compassionate, non-judgmental care to reduce healthcare stigma.
• Felix provides discreet home delivery of medications, enhancing privacy and convenience.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$24.8M

Below

Industry Average

Funded Over

3 Rounds

$13,200,000

Series B

Apr 2023

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.

Series B Funding Comparison

Below Average

Industry standards

Ind Avg. $35M

$4M

$13.2M

$30M

$45M

$65M

$100M

View all funding stages